<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                                                                                                    Article <br />  <br />                                                                                                                              pubs.acs.org/biochemistry <br />  <br />  <br />  <br />  <br /> Mechanism Feedback Allosteric Inhibition ATP <br /> Phosphoribosyltransferase <br /> So&#204;&#8364;nia Pedren&#204;&#402;o,&#226;&#8364;&#160; Joao&#204;&#402; Pedro Pisco,&#226;&#8364;&#160; Ge&#204;?rald Larrouy-Maumus,&#226;&#8364;&#160; Geo&#239;&#172;&#8364; Kelly,&#226;&#8364;&#161; <br /> and Luiz Pedro So&#204;?rio Carvalho*,&#226;&#8364;&#160; <br /> &#226;&#8364;&#160; <br /> Mycobacterial Research Division, MRC National Institute Medical Research, &#226;&#8364;&#161;MRC Biomolecular NMR Centre, The <br /> Ridgeway, Mill Hill, London NW7 1AA, U.K. <br />  <br />  <br />  <br />  <br />     <span id='am-1' about='protege:abstract' typeof='owl:Thing'>ABSTRACT</span>: MtATP-phosphoribosyltransferase catalyzes &#239;&#172;?rst committed step L-histidine biosynthesis in <br />     Mycobacterium tuberculosis subjected allosteric feedback regulation. Because essentiality, enzyme <br />     studied potential target novel anti-infectives. <span id='am-4' about='protege:TO' typeof='owl:Thing'>To</span> understand basis regulation, characterized the <br />     allosteric inhibition using gel &#239;&#172;?ltration, steady-state pre-steady-state kinetics, pH dependence inhibition and <br />     binding. Gel &#239;&#172;?ltration experiments indicate MtATP-phosphoribosyltransferase hexamer solution, presence or <br />     absence L-histidine. Steady-state kinetic studies demonstrate L-histidine inhibition uncompetitive versus ATP and <br />     noncompetitive versus PRPP. At pH values close neutrality, Kii value 4 &#206;&#188;M obtained L-histidine. Pre-steady-state <br />     kinetic experiments indicate chemistry rate-limiting overall reaction L-histidine inhibition caused by <br />     trapping enzyme inactive conformation. The pH dependence binding, obtained nuclear magnetic resonance, <br />     indicates L-histidine binds better neutral &#206;&#177;-amino group. The pH dependence inhibition (Kii), contrary, <br />     indicates L-histidine better inhibits MtATP-phosphoribosytransferase neutral imidazole ionized &#206;&#177;-amino <br />     group. These results combined model accounts allosteric inhibition MtATP-phosphoribosyltransferase. <br />  <br />  <br />                                                                             active site enzyme deemed &#226;&#8364;&#339;not targetable&#226;&#8364;? poor <br /> F    eedback allosteric inhibition metabolic enzymes one <br />      e&#239;&#172;&#402;cient mechanisms maintained through <br /> evolution control &#239;&#172;&#8218;ux biochemical pathways.1&#226;&#710;&#8217;3 <br />                                                                             &#226;&#8364;&#339;ligandability&#226;&#8364;?.7,8 A examples important enzymes that <br />                                                                             successfully targeted allosteric site pyruvate <br /> E&#239;&#172;&#402;ciency comes direct, speci&#239;&#172;?c, nearly instanta-                 kinase (as potential antihyperglycemic therapy),9 mitotic <br /> neous e&#239;&#172;&#8364;ect, permits dynamic control &#239;&#172;&#8218;ux               kinesin (involved centrosome separation formation of <br /> biochemical pathways. In addition, feedback inhibition                   bipolar mitotic spindle),10 Staphylococcus aureus D- <br /> independent transcription, translation, intricate signal             alanine:D-alanine ligase (involved peptidoglycan biosyn- <br /> transduction cascades.                                                      thesis),11 Cdc34 ubiquitin-conjugatin enzyme (active <br />    Natural feedback inhibitors serve templates              certain prostate colorectal cancer cell lines),12 and <br /> chemically diverse, allosteric small molecule inhibitors,             Haemophilus inf luenzae HslUV protease (a bacterial version <br /> are currently intensely sought probes chemical biology               proteosome).13 <br /> and chemical genetics, regulators synthetic biology,                A remarkable example allosterically regulated enzyme is <br /> as therapeutics diseases. In addition qualities          ATP phosphoribosyltransferase (ATP-PRT), encoded the <br /> described above, allosteric inhibitors display                  hisG gene Mycobacterium tuberculosis. MtATP-PRT catalyzes <br /> appealing features small molecule therapeutics. For instance,            &#239;&#172;?rst committed step L-histidine biosynthesis (Scheme 1) <br /> allosteric inhibitors potential noncompetitive            inhibited end product pathway, L- <br /> uncompetitive versus particular substrate4 time-depend- <br /> ent5,6 target sites enzyme active              Received: June 18, 2012 <br /> site. For reasons, allosteric inhibitors target              Revised: August 22, 2012 <br /> feedback site compounds choice                     Published: September 18, 2012 <br />  <br />                                &#194;&#169; 2012 American Chemical Society      8027                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                        Article <br />  <br /> Scheme 1                                                                   validation, i.e., essentiality reaction pathway <br />                                                                            M. tuberculosis, con&#239;&#172;?rmed high-resolution <br />                                                                            transposon mutagenesis18 clean genetic knockouts other <br />                                                                            enzymes pathway.19 In addition, pathway absent in <br />                                                                            humans, suggests priori toxicity associated with <br />                                                                            potential inhibitors. <br />                                                                               ATP-PRTs (EC 2.4.2.17) catalyze reversible, Mg2+- <br />                                                                            dependent formation 1-(5-phospho-&#206;&#177;-D-ribosyl)-ATP (PR- <br />                                                                            ATP) inorganic pyrophosphate (PPi) ATP 5- <br />                                                                            phospho-&#206;&#177;-D-ribosyl pyrophosphate (PRPP) (Scheme 2). <br />                                                                            Some ATP-PRTs activated K+.20 This reaction <br />                                                                            shown proceed directly, generation a <br />                                                                            covalent intermediate,21 follow sequential ordered <br />                                                                            kinetic mechanism ATP &#239;&#172;?rst substrate bind and <br />                                                                            PR-ATP product dissociate.22 Interestingly, ATP- <br />                                                                            PRT anthranilate-PRT phosphoribosyltrans- <br />                                                                            ferases (PRTs) described day involved in <br />                                                                            nucleoside NAD+/NADP+ metabolism. Common ribosyl <br />                                                                            acceptors used PRTs orotate, nicotinamide/ <br />                                                                            nicotinate, adenine, hypoxanthine/guanine. <br />                                                                               With regard tertiary quaternary structure, are <br />                                                                            types ATP-PRTs. They widespread <br />                                                                            homohexameric form, encountered bacteria, fungi, and <br />                                                                            plants, hetero-octameric form, restricted some <br />                                                                            bacteria. MtATP-PRT belongs homohexameric class,16 <br />                                                                            Salmonella enterica Escherichia <br />                                                                            coli.23,24 Crystallographic data suggested MtATP-PRT an <br />                                                                            active dimer associates inactive hexamer, L- <br />                                                                            histidine binding.16 In addition, L-histidine-bound hexame- <br />                                                                            ric form displays major conformational change, twist of <br />                                                                            domain III relative domains I II. Crystallographic studies <br />                                                                            revealed L-histidine binds site &#226;&#710;&#188;30 &#195;&#8230; the <br />                                                                            active site, con&#239;&#172;?rming inhibition allosteric nature. <br />                                                                            Finally, shown L-histidine held allosteric site <br />                                                                            interactions carboxyl group Asp218, the <br />                                                                            hydroxyl Thr238, backbone amide oxygen <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br />                                                                            Ala273.16 <br />                                                                               Because L-histidine&#226;&#8364;&#8482;s imidazole group displays pKa near <br />                                                                            neutrality (&#226;&#710;&#188;6.0), de&#239;&#172;?ne ionic form <br />                                                                            binds inhibits MtATP-PRT. This question been <br />                                                                            partially answered homologous enzymes S. enterica <br />                                                                            (SeATP-PRT) Corynebacterium glutamicum (CgATP- <br />                                                                            PRT).23,25 With SeATP-PRT, L-histidine shown inhibit <br />                                                                            better higher pH values, indicating imidazole ring is <br />                                                                            deprotonated. In contrast, CgATP-PRT, lower pH values <br />                                                                            increased potency, suggesting protonated imidazole form <br />                                                                            inhibits better. Unfortunately, studies used &#226;&#8364;&#339;IC50&#226;&#8364;? &#226;&#8364;&#339;% <br />                                                                            activity&#226;&#8364;? surrogates a&#239;&#172;&#402;nity, instead Ki Kd values, <br />                                                                            making interpretation results di&#239;&#172;&#402;cult. Currently, no <br />                                                                            information ionic state L-histidine inhibition of <br />                                                                            MtATP-PRT available. <br />                                                                               In work, detailed characterization the <br />                                                                            mechanism allosteric inhibition MtATP-PRT L- <br />                                                                            histidine. We use combination steady-state pre- <br />                                                                            steady-state kinetics, pH studies, 1H NMR spectroscopy, and <br />                                                                            gel &#239;&#172;?ltration experiments characterize L-histidine <br />                                                                            allosterically controls MtATP-PRT. Our results combined <br />                                                                            structural data available generate new model that <br />                                                                            accounts inhibition. <br /> histidine.14,15 In M. tuberculosis, hisG gene predicted to <br /> share operon enzyme pathway, encoded <br /> by hisE gene. MtATP-PRT proposed potential <br />                                                                            &#226;&#8211;&#160;  MATERIALS AND METHODS <br />                                                                              Materials. Bu&#239;&#172;&#8364;ers purchased Fisher Scienti&#239;&#172;?c. <br /> target development novel anti-TB agents.16,17 Target            Unless stated, chemicals purchased <br />                                                                     8028                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                       Article <br />  <br /> Scheme 2 <br />  <br />  <br />  <br />  <br /> from Sigma-Aldrich. Baker&#226;&#8364;&#8482;s yeast inorganic pyrophosphatase                   For pre-steady-state kinetic experiments, larger <br /> was purchased Sigma-Aldrich. M. tuberculosis inorganic                amounts inorganic pyrophosphatase required, used <br /> pyrophosphatase (Rv3628) produced laboratory (L.                recombinant inorganic pyrophosphatase M. tuberculosis <br /> P. Carvalho, unpublished results). Chromatographic columns                 produced laboratory (L. P. Carvalho, unpublished <br /> were purchased GE, Ni-NTA resin purchased                     results). <br /> from EMD. Complete EDTA-Free protease inhibitor                           Gel Filtration. The solution oligomeric state MtATP- <br /> purchased Roche. BL21(DE3)pLysS EMD.                         PRT determined using Sephacryl S-200 column and <br />    General Methods Equipment. The protein concen-                      molecular weight standards (Bio-Rad). Typically, 100 &#206;&#188;L of <br /> tration measured using BCA assay Pierce, using                MtATP-PRT concentrations ranging 0.1 10 mg/mL <br /> bovine serum albumin standard. Protein puri&#239;&#172;?cation                injected. Protein eluted isocratically 1.5 column <br /> performed using AKTA puri&#239;&#172;?er 10 (GE Healthcare). SDS&#226;&#710;&#8217;                   volumes, rate 0.5 mL/min. The bu&#239;&#172;&#8364;er 20 mM Tris- <br /> PAGE performed PhastSystem (GE Healthcare).                       HCl (pH 8) containing 100 mM NaCl, 2 mM <br /> Spectrophotometry conducted Shimadzu UV-2550                    L-histidine. <br /> spectrophotometer equipped dual-beam optics                        Measurement Enzymatic Activity. Initial velocities for <br /> Peltier temperature control. Stopped-&#239;&#172;&#8218;ow absorb-                forward reaction MtATP-PRT measured by <br /> ance spectroscopy conducted Applied Photophysics                 following formation PR-ATP (&#206;&#181;290 = 3600 M&#226;&#710;&#8217;1 <br /> SX-20 stopped-&#239;&#172;&#8218;ow spectrophotometer, equipped                       cm&#226;&#710;&#8217;1),26 presence inorganic pyrophosphatase. <br /> circulating water bath. Under conditions, dead time              Pyrophosphatase essential assay, equilibrium <br /> was estimated 3 ms. Experiments conducted                    constant lies formation ATP PRPP. A typical <br /> mixing equal volumes solutions, containing enzyme               reaction mixture contained 50 mM Tris-HCl (pH 8.5), 7 mM <br /> and the variable substrate L-histidine.          MgCl2, 200 mM KCl, 800 &#206;&#188;M ATP, 400 &#206;&#188;M PRPP, 3 milliunits <br /> NMR experiments conducted using Varian Inova                        pyrophosphatase, 150 nM MtATP-PRT. All activity <br /> spectrometer 14.4 T. All assays conducted 25 &#194;&#176;C. All            assays performed 25 &#194;&#177; 0.2 &#194;&#176;C. <br />                                                                               1 <br /> concentrations MtATP-PRT reported &#239;&#172;?nal                               H NMR Spectroscopy. One-dimensional spectra L- <br />                                                                            histidine function pH recorded using excitation <br /> concentrations used, monomer. <br />                                                                            sculpting27 water suppression. STD spectra recorded <br />    Plasmid Preparation, Protein Expression, Puri&#239;&#172;?- <br />                                                                            interleaved manner range saturation times (0.2&#226;&#710;&#8217; <br /> cation. The Rv2121c gene sequence M. tuberculosis <br />                                                                            2.0 s 0.2 s intervals) on-resonance presaturation the <br /> H37Rv codon adapted E. coli, nucleotide <br />                                                                            enzyme 0.8 ppm. A single o&#239;&#172;&#8364;-resonance control spectrum <br /> sequence synthetically prepared ligated pJ411 <br />                                                                            recorded saturation time 2 s. Water suppression <br /> plasmid (DNA 2.0). DNA sequence con&#239;&#172;?rmed                            achieved excitation sculpting. Data processing, spectral <br /> sequencing. This construct contained noncleavable N-                     subtractions, quantitation performed using VNMRJ <br /> terminal hexahistidine tag facilitate puri&#239;&#172;?cation. The N-               1.1D. The physical basis saturation transfer di&#239;&#172;&#8364;erence NMR <br /> terminal hexahistidine tag shown a&#239;&#172;&#8364;ect structure            described elsewhere.28,29 <br /> or activity MtATP-PRT.16                                                   Inhibition Studies. To determine inhibition constants and <br />    During MtATP-PRT puri&#239;&#172;?cation, steps performed               inhibition patterns associated L-histidine, MtATP-PRT <br /> 4 &#194;&#176;C. Frozen BL21(DE3)pLysS (pJ411::hisG) cells                       activity studied presence variable concentrations <br /> thawed ice, lysed sonication, presence                 substrate, &#239;&#172;?xed saturating concentrations other <br /> bu&#239;&#172;&#8364;er A [20 mM triethanolamine (TEA) (pH 7.8), 300 mM                      substrate metals, &#239;&#172;?xed concentrations L- <br /> NaCl, 50 mM imidazole] containing lysozyme                         histidine. <br /> Complete EDTA-free protease inhibitor cocktail. Soluble                       pH Studies. To determine e&#239;&#172;&#8364;ect pH the <br /> protein obtained centrifugation 25000g 30 min.               inhibitory activity L-histidine, MtATP-PRT activity was <br /> The soluble fraction loaded 50 mL Ni-NTA column                 studied presence variable concentrations ATP, &#239;&#172;?xed <br /> and protein separated gradient using bu&#239;&#172;&#8364;er B [20 mM               saturating concentrations PRPP metals, &#239;&#172;?xed <br /> TEA (pH 7.8), 300 mM NaCl, 500 mM imidazole]. Peak                     concentrations L-histidine, di&#239;&#172;&#8364;erent pHs ranging 6.5 <br /> fractions analyzed SDS&#226;&#710;&#8217;PAGE. Fractions containing                  9.5 (in HEPES, PIPES, TAPS, CHES bu&#239;&#172;&#8364;ers). Because <br /> only MtATP-PRT pooled together, concentrated, dialyzed                narrow pH range MtATP-PRT, inhibition <br /> in 20 mM TEA (pH 7.8), stored 50% glycerol &#226;&#710;&#8217;20 &#194;&#176;C                data pH 8 9.25 analyzed (TAPS pH 8.0 to <br /> or, alternatively, stored &#226;&#710;&#8217;80 &#194;&#176;C &#239;&#172;&#8218;ash-frozen             8.75 CHES pH 9.0 9.25). Between pH 8 9.25, <br /> liquid nitrogen. This protocol allowed puri&#239;&#172;?cation                  PRPP concentrations tested shown saturating. <br /> homogeneity 114 mg MtATP-PRT 15 g wet cell                      Pre-Steady-State Kinetics. Photomultiplier voltage was <br /> pellet. Puri&#239;&#172;?ed ATP-PRT analyzed electrospray                       zeroed bu&#239;&#172;&#8364;er. A cell 10 mm path <span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> used <br /> ionization mass spectrometry (ESI-MS) con&#239;&#172;?rm protein                    experiments. All experiments performed 25 &#194;&#176;C in <br /> identity (NIMR Mass Spectrometry Facility).                                50 mM Tris-HCl (pH 8.5) containing 150 mM KCl, 10 mM <br />                                                                     8029                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                          Article <br />  <br /> MgCl2, 1.5 mM PRPP, 60 &#206;&#188;M pyrophosphatase, 10 &#206;&#188;M                                       &#226;&#381;&#161;                                                    &#226;&#381;&#164; <br /> MtATP-PRT. Higher concentrations substrates metals                                 { <br />                                                                                  A = A max &#226;&#381;&#163;E + S + Kdapp &#226;&#710;&#8217;              (E + S + Kdapp)2 &#226;&#710;&#8217; 4ES &#226;&#381;&#166; <br /> were used, precipitation. Typically, 10 progress <br /> curves 1000 points averaged data                           /(2E)} <br />                                                                                                                                                             (8) <br /> &#239;&#172;?t. Rates amplitudes obtained &#239;&#172;?tting average to <br /> the burst equation (eq 7). Mixing achieved rapid                      Amax amplitude maximum, E concentration <br /> combination 60 &#206;&#188;L syringe. The e&#239;&#172;&#8364;ect                         enzyme, S total concentration ATP, Kapp <br />                                                                                                                                       d is <br /> increasing concentrations ATP (from 0.025 4 mM) L-                 apparent dissociation constant ATP. Similarly, the <br /> histidine (from 5 80 &#206;&#188;M) rate reaction                  dependence kobs ATP concentration conditions <br /> measured monitoring conversion ATP PR-ATP,                   substrate enzyme concentrations comparable was <br /> observing increase absorbance 290 nm.                              &#239;&#172;?t eq 9 <br />    Data Analysis. Steady-state NMR data &#239;&#172;?t using <br />                                                                                                 &#226;&#381;&#161; <br /> the nonlinear, least-squares, curve-&#239;&#172;?tting programs Sigma- <br /> Plot Windows, version 11.0. Pre-steady-state data &#239;&#172;?t <br />                                                                                              { <br />                                                                                  kobs = k burst &#226;&#381;&#163;E + S + Kdapp <br />  <br /> using KinTek Global Kinetic Explorer,30,31 version 3.0.                                                             &#226;&#381;&#164; <br /> Individual saturation curves &#239;&#172;?t eq 1 <br />                                                                                         &#226;&#710;&#8217;    (E + S + Kdapp)2 &#226;&#710;&#8217; 4ES &#226;&#381;&#166; /(2E)              }                  (9) <br />  <br />    v = VA /(A + K )                                            (1)           kburst maximal burst rate. The dependence the <br />                                                                              burst amplitude L-histidine concentration &#239;&#172;?t to <br /> where V maximal velocity, A substrate metal <br /> concentration, K Michaelis constant substrate                 A = (A 0Kd)/(Kd + [I])                                                    (10) <br /> (Km) constant metal (Kact). Individual saturation                 A0 maximal amplitude (in absence L- <br /> curves showing substrate inhibition <span id='am-84' about='xsp:pattern' typeof='owl:Thing'>pattern</span> &#239;&#172;?t eq 2                  histidine) [I] concentration L-histidine. The <br />                                                                              dependence kobs concentration L-histidine was <br />    v = VA /[K act + A(1 + A /K iapp)]                          (2)           described one-step binding mechanism, according eq 11 <br /> where Kapp <br />           apparent inhibition constant A. Inhibition                kobs = kon[I] + koff                                                      (11) <br /> data, recorded saturating concentrations ATP, PRPP, <br /> Mg2+, K+ variable concentration L-histidine, &#239;&#172;?t              kon second-order association rate constant koff <br /> to eq 3                                                                      unimolecular dissociation rate constant. <br />  <br />    v = v0/[1 + (I /IC50)nH ]                                   (3)           &#226;&#8211;&#160;    RESULTS <br />                                                                                 MtATP-PRT Puri&#239;&#172;?cation. The hisG (rv2121) gene <br /> where v0 uninhibited velocity, I L-histidine                   sequence M. tuberculosis H37Rv codon-adapted to <br /> concentration, IC50 concentration L-histidine necessary            E. coli chemically synthesized ligated pJ411, <br /> to 50% inhibition, nH Hill number. Inhibition                nucleotide sequence con&#239;&#172;?rmed (DNA 2.0); 7.6 mg <br /> data showing linear, noncompetitive, uncompetitive patterns               MtATP-PRT puri&#239;&#172;?ed gram BL21(DE3)pLysS <br /> in double-reciprocal plots &#239;&#172;?t eqs 4 5                            (pJ411::hisG), using single Ni-NTA chromatographic step. <br />    v = VA /[K (1 + I /K is) + A(1 + I /K ii)]                  (4)           Puri&#239;&#172;?ed MtATP-PRT subjected ESI-MS identi- <br />                                                                              &#239;&#172;?cation. The puri&#239;&#172;?ed protein exhibited molecular mass of <br />                                                                              31,515.1 Da, experimental error the <br />    v = VA /[K + A(1 + I /K ii)]                                (5)           calculated molecular mass 31515.6 Da. This result con&#239;&#172;?rms <br />                                                                              identity enzyme used following experiments. <br /> where Kis Kii slope intercept inhibition <br />                                                                                 Oligomeric State MtATP-PRT. We determined the <br /> constants, respectively. NMR chemical shift data showing a <br />                                                                              apparent solution molecular mass MtATP-PRT using gel <br /> single titration event &#239;&#172;?t variation Henderson&#226;&#710;&#8217; <br />                                                                              &#239;&#172;?ltration, Sephadex S200 column. Figure 1 depicts <br /> Hasselbalch equation32 <br />                                                                              representative chromatograms obtained, showing the <br />    &#206;&#180; = (&#206;&#180;acid + &#206;&#180; base10 pH &#226;&#710;&#8217; pKa)/(1 + 10 pH &#226;&#710;&#8217; pKa)                         mycobacterial enzyme behaves single species solution, <br />                                                                (6) <br />                                                                              apparent molecular mass &#226;&#710;&#188;180 kDa. This molecular <br /> where &#206;&#180; instantaneous chemical shift parts million,            mass consistent hexameric form. The repetition this <br /> &#206;&#180;acid chemical shift protonated form, &#206;&#180;<span id='am-83' about='xsp:base' typeof='owl:Thing'>base</span>             experiment lower concentrations protein yields same <br /> chemical shift deprotonated form, pH                           result, indicating MtATP-PRT does display a <br /> antilogarithm concentration protons, pKa                concentration-dependent change oligomeric state at <br /> acid dissociation constant group titrated. Pre-                protein concentrations ranging 0.1 10 mg/mL. <br /> steady-state burst kinetic data &#239;&#172;?t eq 7                              Repetition experiment presence 2 mM L- <br />                                                                              histidine (Figure 1) showed overall result. Repetition <br />    Yt = A e&#226;&#710;&#8217;kobst + vt + C                                     (7)           experiment presence ATP (the &#239;&#172;?rst substrate to <br />                                                                              bind ATP-PRTs) did yield observable change the <br /> where Yt observed signal time t, A amplitude             apparent molecular mass (data shown). These results <br /> the transient, kobs observed burst rate transient, v          indicate MtATP-PRT hexamer solution this <br /> is linear rate, C o&#239;&#172;&#8364;set linear phase. The              oligomeric state in&#239;&#172;&#8218;uenced allosteric inhibitor or <br /> dependence burst amplitude ATP concentration                       ATP, &#239;&#172;?rst substrate. <br /> under conditions substrate enzyme concentration                       Steady-State Kinetics Inhibition Studies. MtATP- <br /> were comparable described eq 833                                       PRT displays Michaelis&#226;&#710;&#8217;Menten kinetics substrates <br />                                                                       8030                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                                      Article <br />  <br />                                                                                    product, PR-ATP, potent inhibitor ATP-PRTs.34 <br />                                                                                    Interestingly, MtATP-PRT displays low activity neutral <br />                                                                                    acidic pH. Therefore, lowest pH used kinetic <br />                                                                                    studies 8.0. No activity observed presence of <br />                                                                                    metal-chelating agent EDTA, indicating Mg2+ essential <br />                                                                                    activity rapidly dissociating enzyme (data <br />                                                                                    shown). Addition thiol reducing agent DTT did not <br />                                                                                    alter time course (data shown), indicating this <br />                                                                                    enzyme preparation did contain oxidized cysteine residues <br />                                                                                    disul&#239;&#172;?de bonds inhibit activity. <br />                                                                                       Apparent Km values obtained ATP (263 &#194;&#177; 63 &#206;&#188;M) <br />                                                                                    presence saturating concentrations PRPP and <br />                                                                                    MgCl2 200 mM KCl (Figure 2, panel) PRPP <br />                                                                                    (49 &#194;&#177; 6 &#206;&#188;M) presence saturating levels ATP, <br />                                                                                    MgCl2, KCl (Figure 2, middle panel). As observed with <br /> Figure 1. MtATP-PRT hexameric solution presence                   SeATP-PRT,22 high concentrations MgCl2 led inhibition <br /> absence L-histidine. Gel &#239;&#172;?ltration experiment illustrating lack          MtATP-PRT. Apparent Kact Ki values obtained for <br /> change oligomeric state MtATP-PRT. Solid dashed lines                MgCl2 (1.9 &#194;&#177; 0.6 23.3 &#194;&#177; 8.6 mM, respectively) the <br /> are representative chromatographic traces MtATP-PRT (100 &#206;&#188;g)                    presence saturating concentrations substrates and <br /> analyzed Sephacryl S200 absence presence 2 mM                 200 mM KCl (data shown). The e&#239;&#172;&#8364;ect K+ rate of <br /> L-histidine, respectively. These experiments performed 20 mM <br /> Tris-HCl (pH 8) containing 100 mM NaCl. Results representative <br />                                                                                    MtATP-PRT saturable; therefore, performed the <br /> of independent experiments.                                                   experiments 200 mM KCl (data shown). Steady-state <br />                                                                                    data summarized Table 1. <br />  <br /> (Figure 2). Time courses linear minutes (data                   Table 1. Steady-State Pre-Steady-State Kinetic <br /> not shown), consistent previous observations                    Parameters MtATP-PRTa <br />                                                                                               parameter                            best &#239;&#172;?t                   equation <br />                                                                                         Vmax (s&#226;&#710;&#8217;1)                              0.31 &#194;&#177; 0.01                      1 <br />                                                                                         Km,ATP (&#206;&#188;M)                             263 &#194;&#177; 63                         1 <br />                                                                                         Km,PRPP (&#206;&#188;M)                            49 &#194;&#177; 6                           1 <br />                                                                                         Kact,Mg2+ (&#206;&#188;M)                          1900 &#194;&#177; 600                       2 <br />                                                                                         Ki,Mg2+ (&#206;&#188;M)                            23000 &#194;&#177; 900                      2 <br />                                                                                         IC50,L&#226;&#8364;&#8216;histidine (&#206;&#188;M)                   33 &#194;&#177; 3                           3 <br />                                                                                         Amax (&#206;&#188;M)                               7.8 &#194;&#177; 0.3                        8 <br />                                                                                         Kapp <br />                                                                                           d,ATP (&#206;&#188;M)                            47.2 &#194;&#177; 10.3                      8 <br />                                                                                         Kburst (s&#226;&#710;&#8217;1)                            0.67 &#194;&#177; 0.02                      9 <br />                                                                                         Kd,L&#226;&#8364;&#8216;histidine (&#206;&#188;M)                     27.9 &#194;&#177; 3.2                       10 <br />                                                                                         kon,L&#226;&#8364;&#8216;histidine (M&#226;&#710;&#8217;1 s&#226;&#710;&#8217;1)               4885 &#194;&#177; 717                       11 <br />                                                                                         koff,L&#226;&#8364;&#8216;histidine (s&#226;&#710;&#8217;1)                  0.95 &#194;&#177; 0.03                      11 <br />                                                                                    a <br />                                                                                      Assays performed 50 mM bu&#239;&#172;&#8364;er, containing MgCl2 KCl, the <br />                                                                                    speci&#239;&#172;?ed values, 25 &#194;&#176;C. See Materials Methods bu&#239;&#172;&#8364;ers <br />                                                                                    concentrations substrates, metals, L-histidine. <br />  <br />                                                                                       We con&#239;&#172;?rmed inhibition MtATP-PRT L- <br />                                                                                    histidine determining IC50. As seen Figure 2 <br />                                                                                    (bottom panel), preparation MtATP-PRT readily <br />                                                                                    inhibited L-histidine. Under experimental conditions, the <br />                                                                                    IC50 obtained L-histidine 33.3 &#194;&#177; 3.5 &#206;&#188;M Hill <br />                                                                                    number 1.5 (Table 1). To obtain inhibition constants (Ki), <br />                                                                                    independent concentration enzyme, <br /> Figure 2. Steady-state kinetics MtATP-PRT inhibition L-              substrates, metal ions used,35 de&#239;&#172;?ne nature of <br /> histidine. The middle panels saturation curves                inhibition, performed single inhibition studies &#239;&#172;?xed <br /> ATP (&#226;&#8212;?) PRPP (&#226;&#8212;&#8249;), respectively. These experiments                         saturating concentration substrate &#239;&#172;?xed variable <br /> performed 25 &#194;&#176;C, 50 mM Tris-HCl (pH 8.5) containing 7 mM                     concentrations second substrate. Inhibition L-histidine <br /> MgCl2 200 mM KCl. When ATP concentration varied,                       versus PRPP linear noncompetitive (Figure 3), a <br /> the PRPP concentration 0.8 mM. When PRPP concentration                     set lines intersecting left Y-axis double- <br /> was varied, ATP concentration 1.6 mM. The panel <br /> shows inhibition (at single substrate concentration) MtATP- <br />                                                                                    reciprocal plot, Kii value 23.5 &#194;&#177; 6.5 &#206;&#188;M Kis value <br /> PRT L-histidine (&#226;&#8212;?). This experiment performed 25 &#194;&#176;C,                 25.7 &#194;&#177; 12.8 &#206;&#188;M. As Kii Kis values identical within <br /> 50 mM Tris-HCl (pH 8.5) containing 7 mM MgCl2, 200 mM KCl, 1.6                     experimental error, L-histidine appears a&#239;&#172;&#402;nity <br /> mM ATP, 0.8 mM PRPP. Points data lines best &#239;&#172;?t eq 1                 enzyme presence absence PRPP. When the <br /> (top middle panels) eq 2 (bottom panel). Results                       ATP concentration varied, L-histidine inhibition linear <br /> representative independent experiments.                                     uncompetitive (Figure 4), set parallel lines a <br />                                                                             8031                              dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                            Article <br />  <br />  <br />  <br />  <br /> Figure 3. Inhibition MtATP-PRT L-histidine vs PRPP. (A) Double-reciprocal plot illustrating linear noncompetitive inhibition pattern <br /> obtained varying concentration L-histidine &#239;&#172;?xed variable concentrations PRPP &#239;&#172;?xed saturating concentrations ATP, Mg2+, <br /> and K+. Data obtained 50 mM Tris-HCl (pH 8.5) 25 &#194;&#176;C. Results representative independent experiments. Points data <br /> obtained 0 (&#226;&#8212;?), 15 (&#226;&#8212;&#8249;), 30 (&#226;&#8211;&#160;), 45 &#206;&#188;M L-histidine (&#226;&#8211;&#161;), error bars indicate standard deviation. Lines best &#239;&#172;?t entire <br /> data set eq 3. (B) Replot intercept data shown panel A (top), showing linear dependence inhibitor concentration. Replot of <br /> the slope data shown panel A (bottom), showing linear dependence inhibitor concentration. Points data, line linear <br /> regression data. <br />  <br />  <br />  <br />  <br /> Figure 4. Inhibition MtATP-PRT L-histidine vs ATP. (A) Double-reciprocal plot illustrating linear uncompetitive inhibition pattern <br /> obtained varying concentration L-histidine &#239;&#172;?xed variable concentrations ATP &#239;&#172;?xed saturating concentrations PRPP, Mg2+, <br /> and K+. Data obtained 50 mM Tris-HCl (pH 8.5) 25 &#194;&#176;C. This result representative independent experiments. Points data <br /> obtained 0 (&#226;&#8212;?), 15 (&#226;&#8212;&#8249;), 30 (&#226;&#8211;&#160;), 45 &#206;&#188;M L-histidine (&#226;&#8211;&#161;), error bars indicate standard deviation. Lines best &#239;&#172;?t entire <br /> data set eq 4. (B) Replot intercept data shown panel A, showing linear dependence inhibitor concentration. Points data, <br /> and line linear regression data. <br />  <br /> double-reciprocal plot, Kii value 27.9 &#194;&#177; 1.9 &#206;&#188;M. This                STD experiments, recorded spectra L-histidine a <br /> result indicates binding ATP essential inhibition            function pH determine ionization states our <br /> L-histidine. Inhibition data summarized Table 2.                        experimental conditions pH-dependent changes the <br />    Ionic States L-Histidine Interaction                            chemical shifts sets protons L-histidine <br /> MtATP-PRT. To de&#239;&#172;?ne ionic state L-histidine bound                       (Figure 5A). The chemical shift protons in&#239;&#172;&#8218;uenced <br /> to MtATP-PRT, &#239;&#172;?rst employed equilibrium &#239;&#172;&#8218;uorescence                         pH shown Figure 5B. Taken together, results <br /> measurements. Unfortunately, binding L-histidine                       indicate experimental conditions protons C&#206;&#180;2- <br /> modestly alters intrinsic tryptophan &#239;&#172;&#8218;uorescence spectrum                  H, C&#206;&#181;1-H, C&#206;&#177;-H coupled report on <br /> of MtATP-PRT (data shown), precluding quantitative                         ionization imidazole ring. On hand, protons <br /> analysis. As alternative &#239;&#172;&#8218;uorescence, employed 1H                     C&#206;&#178;-H2 inform ionization &#206;&#177;-amino group. Data <br /> NMR characterize interaction. We reasoned STD-                    shown Figure 5C Table 3 indicate L-histidine bound <br /> NMRa constitute simple e&#239;&#172;&#402;cient way                              MtATP-PRT subjected saturation transfer, as <br /> monitoring ligand binding di&#239;&#172;&#8364;erent pH values. Before                    expected, process in&#239;&#172;&#8218;uenced pH. Speci&#239;&#172;?cally, <br />                                                                         8032                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                             Article <br />  <br /> Table 2. Steady-State Inhibition Constants MtATP-PRT <br /> and L-Histidinea <br />              varied       inhibition <br />     pH     substrateb      patternc       Kii (&#206;&#188;M)          Kis (&#206;&#188;M) <br />     8.50     PRPP            NC           23.5   &#194;&#177;   6.5   25.7 &#194;&#177; 12.8 <br />     8.50     ATP             UC           27.9   &#194;&#177;   1.9   &#226;&#710;&#8217; <br />     8.00     ATP             UC            4.0   &#194;&#177;   0.4   &#226;&#710;&#8217; <br />     8.25     ATP             UC            7.9   &#194;&#177;   1.5   &#226;&#710;&#8217; <br />     8.50     ATP             UC           28.3   &#194;&#177;   2.1   &#226;&#710;&#8217; <br />     8.75     ATP             UC           26.8   &#194;&#177;   1.5   &#226;&#710;&#8217; <br />     9.00     ATP             UC           50.4   &#194;&#177;   5.5   &#226;&#710;&#8217; <br />     9.25     ATP             UC          109.4   &#194;&#177;   6.8   &#226;&#710;&#8217; <br /> a <br />  Assays performed 50 mM bu&#239;&#172;&#8364;er containing 7 mM MgCl2 200 <br /> mM KCl, speci&#239;&#172;?ed pH values, 25 &#194;&#176;C. See Materials and <br /> Methods bu&#239;&#172;&#8364;ers pH. bThe concentrations of <br /> cosubstrates held &#239;&#172;?xed (0.8 mM PRPP 1.6 mM ATP). cNC, <br /> noncompetitive; UC, uncompetitive. <br />  <br /> saturation transfer neglible lower pH values (&lt;7.5) and <br /> maximal high pH values (&#226;&#710;&#188;9), indicating neutral <br /> imidazole deprotonated &#206;&#177;-amino group favor binding. The <br /> aliphatic protons appear pick saturation (Table 3), <br /> indicating looser contact protein, compared that <br /> of imidazole protons. <br />    pH&#226;&#710;&#8217;Rate Studies. To investigate e&#239;&#172;&#8364;ect pH the <br /> allosteric inhibition, determined Kii values L- <br /> histidine, varying ATP concentration &#239;&#172;?xed saturating <br /> concentration PRPP, various pH values. As in <br /> Figure 6 Table 2, L-histidine inhibition dependent pH, <br /> but surprisingly, pH dependence inhibition the <br /> opposite observed binding (inhibition weaker <br /> at higher pH values). In pH range 8&#226;&#710;&#8217;9.25, group <br /> being titrated &#206;&#177;-amino group L-histidine, therefore, <br /> we likely observing direct e&#239;&#172;&#8364;ect protonation <br /> state inhibition. Unfortunately, low activity of <br /> MtATP-PRT neutral acidic pH values, not <br /> determine Kii values pH 8.0. Also, pKa values <br /> could derived analysis, slope 1 <br /> was obtained. This result suggests deprotonation &#206;&#177;- <br /> amino group decreases inhibition potency. <br />    Pre-Steady-State Inhibition Studies. To investigate <br /> which elementary steps catalytic cycle directly <br /> a&#239;&#172;&#8364;ected L-histidine, studied inhibition MtATP-PRT <br /> using pre-steady-state kinetics (Table 1). First, characterized <br /> the kinetics absence inhibitor, determine                  Figure 5. Ionic states STD-NMR spectroscopy studies L- <br /> chemistry rate-limiting. As Figure 7,                   histidine binding MtATP-PRT. (A) 1H NMR spectrum L- <br /> multiple-turnover conditions progress curve MtATP-                       histidine 10 mM, 50 mM KPi (pH 8). The asterisk indicates the <br />                                                                                 water signal. (B) Chemical shift dependence pH L-histidine. The <br /> PRT displays burst kinetics. It described single- <br />                                                                                 panel shows data ring protons, C&#206;&#180;2-H (&#226;&#8212;&#8249;) C&#206;&#181;1-H (&#226;&#8212;?). <br /> exponential increase followed steady-state phase (eq 7).                   The panel shows data aliphatic protons, C&#206;&#177;-H (&#226;&#8211;&#161;) and <br /> Burst kinetics diagnostic chemistry faster                     C&#206;&#178;-H (&#226;&#8211;&#160;). Experiments performed 50 mM sodium phosphate <br /> subsequent steps.36,37 In particular case, product (PR-ATP)                bu&#239;&#172;&#8364;er indicated pH values, presence 0.4 mM L-histidine. <br /> formation directly observed, therefore, buildup                     Symbols data, solid lines &#239;&#172;?ts eq 5. (C) pH <br /> product indicates slower steps chemical step. Burst                   dependence STD-NMR L-histidine 30 &#206;&#188;M MtATP-PRT. <br /> kinetics studied varying concentration ATP. As                    Aromatic resonances (C&#206;&#180;2 C&#206;&#181;1) shown. <br /> one Figure 8, quadratic dependence the <br /> burst amplitude ATP concentration exper-                         mentioning that, conditions, Y intercept the <br /> imental conditions (Figure 8B, panel) amplitude                     plot burst dependence ATP concentration zero, <br /> maximum 7.8 &#194;&#177; 0.3 &#206;&#188;M (Table 3). This value close                  indicating slow ATP dissociation. <br /> the actual concentration active sites used (10 &#206;&#188;M),                             We probed e&#239;&#172;&#8364;ect L-histidine, &#239;&#172;?xed saturating <br /> suggesting MtATP-PRT active catalysis.b                     ATP concentration. Two di&#239;&#172;&#8364;erent e&#239;&#172;&#8364;ects observed under <br /> The observed dependence kobs ATP concentration                      multiple-turnover conditions. A marked e&#239;&#172;&#8364;ect burst <br /> also &#239;&#172;?t quadratic equation (Figure 8B, panel),                   amplitude apparent increasing concentrations L- <br /> giving maximal kburst 0.67 &#194;&#177; 0.02 s&#226;&#710;&#8217;1 (Table 1). It worth               histidine (Figure 9A,B). A decrease burst amplitude <br />                                                                          8033                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                                    Article <br />  <br /> Table 3. Saturation Transfer Data L-Histidine and <br /> MtATP-PRTa <br />                         % saturation transfer L-histidine protons <br />     pH           C&#206;&#177;-H            C&#206;&#178;-H2            C&#206;&#180;2-H            C&#206;&#181;1-H <br />     5.5            0               0                0                    0 <br />     6.0            0               0                0                    0 <br />     6.5            0               0                0                    0 <br />     7.5            0               0                0                    0 <br />     8.0            0               0               36.9                 40.4 <br />     8.5            0               0               81.6                 88.2 <br />     9.0            0               0              100                  100 <br /> a <br />   Assays performed 50 mM sodium phosphate bu&#239;&#172;&#8364;er speci&#239;&#172;?ed <br /> pH values 25 &#194;&#176;C, containing 0.6 mM L-histidine 30 &#206;&#188;M HisG. <br />  <br />  <br />  <br />  <br />                                                                                       Figure 8. Pre-steady-state kinetics MtATP-PRT varying ATP <br />                                                                                       concentration. (A) Representative traces MtATP-PRT reaction <br /> Figure 6. pH dependence MtATP-PRT inhibition L-histidine. Kii <br />                                                                                       multiple-turnover conditions obtained di&#239;&#172;&#8364;erent concen- <br /> values obtained varying L-histidine concentration various <br />                                                                                       trations ATP &#239;&#172;?xed saturating concentrations PRPP and <br /> &#239;&#172;?xed concentrations ATP &#239;&#172;?xed saturating concentrations of <br />                                                                                       metals. Gray lines represent data black lines best &#239;&#172;?t eq <br /> PRPP, MgCl2, KCl. All experiments performed 25 &#194;&#176;C. <br />                                                                                       6. Data averages 10 traces. (B) Plot burst amplitude vs <br /> Symbols values obtained speci&#239;&#172;?ed pH values &#239;&#172;?tting data <br />                                                                                       ATP concentration (top) plot kobs vs ATP concentration <br /> to eq 4; error bars represent standard error obtained &#239;&#172;?t to <br />                                                                                       (bottom). Symbols represent data solid lines best &#239;&#172;?t eqs 8 <br /> eq 4, solid line linear regression data. <br />                                                                                       9 burst amplitude burst rate dependencies, respectively. <br />                                                                                       Reactions conducted 50 mM Tris-HCl (pH 8.5), 150 mM <br />                                                                                       KCl, 10 mM MgCl2, 1.5 mM PRPP, 10 &#206;&#188;M MtATP-PRT, 25 <br />                                                                                       &#194;&#176;C. Results representative independent experiments. <br />  <br />                                                                                       chemical steps characterized decrease the <br />                                                                                       steady-state rate burst rate, respectively. A Kd value of <br />                                                                                       27.9 &#194;&#177; 3.2 &#206;&#188;M obtained &#239;&#172;?tting data eq 10, which <br />                                                                                       good agreement Ki value obtained steady-state <br />                                                                                       kinetics. In addition, linear decrease kobs observed (Figure <br />                                                                                       9C,D). <br />  <br />                                                                                       &#226;&#8211;&#160;    DISCUSSION <br />                                                                                          Oligomeric State MtATP-PRT. Our gel &#239;&#172;?ltration <br />                                                                                       experiments indicate MtATP-PRT mainly hexameric in <br />                                                                                       absence ligands presence L-histidine ATP, <br />                                                                                       pH 8. Although result appears contrast the <br />                                                                                       results obtained Cho colleagues,16 dimer&#226;&#710;&#8217;hexamer <br /> Figure 7. Stopped-&#239;&#172;&#8218;ow absorbance time course MtATP-PRT                         equilibrium, believe explained the <br /> reaction. Representative trace MtATP-PRT progress curve (10 <br />                                                                                       experimental conditions used. It worth mentioning no <br /> &#206;&#188;M enzyme), multiple-turnover conditions, obtained at <br /> saturating concentrations ATP PRPP, 50 mM Tris-HCl                          shift oligomeric state observed hexameric <br /> (pH 8.5) 25 &#194;&#176;C. The gray line shows data, black line                       homologous enzyme S. enterica.20,23 Our interpretation of <br /> represents best &#239;&#172;?t burst equation (eq 7). The inset shows                  results lower pH values lead dissociation of <br /> the residuals &#239;&#172;?t burst equation.                                      MtATP-PRT dimers, observed Cho et al. However, <br />                                                                                       evidence dimer represents kinetically <br />                                                                                       competent form MtATP-PRT, activity decreases <br /> indicates L-histidine a&#239;&#172;&#8364;ects MtATP-PRT largely                                drastically pH drops 8. Similar results been <br /> trapping inactive complex. Slower product release                         recently reported ATP-PRT C. glutamicum. Although <br />                                                                                8034                         dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                            Article <br />  <br />                                                                                 conformational changes invoked explain the <br />                                                                                 allosteric inhibition. <br />                                                                                    Inhibition MtATP-PRT L-Histidine. Steady-state <br />                                                                                 kinetic analysis indicates L-histidine inhibition versus PRPP <br />                                                                                 linear noncompetitive, Kis = Kii. The equality of <br />                                                                                 inhibition constants indicates L-histidine the <br />                                                                                 a&#239;&#172;&#402;nity ATP-bound ATP-PRPP-bound enzyme <br />                                                                                 forms. L-Histidine inhibition versus ATP linear and <br />                                                                                 uncompetitive, indicating L-histidine binds MtATP- <br />                                                                                 PRT ATP present enzyme active site. These <br />                                                                                 results fully consistent allosteric inhibition <br />                                                                                 proposed basis structure. In addition, <br />                                                                                 uncompetitive inhibition versus ATP agreement the <br />                                                                                 L-histidine&#226;&#710;&#8217;AMP ternary complex structure determined X- <br />                                                                                 ray crystallography.16 <br />                                                                                    Pre-steady-state kinetic analysis enzyme inhibition a <br />                                                                                 powerful approach determining step steps are <br />                                                                                 a&#239;&#172;&#8364;ected given inhibitor, applied study a <br />                                                                                 number systems, including DNA polymerase &#206;&#179;,38 HIV-1 <br />                                                                                 reverse transcriptase,39 D-3-phosphoglycerate dehydrogenase,40 <br />                                                                                 BACE.41 To gather information L- <br />                                                                                 histidine inhibits MtATP-PRT, performed pre-steady-state <br />                                                                                 kinetic studies, using stopped-&#239;&#172;&#8218;ow absorbance, monitoring PR- <br />                                                                                 ATP formation. L-Histidine inhibition pre-steady-state <br />                                                                                 conditions complex, a&#239;&#172;&#8364;ecting multiple steps. The dominant <br />                                                                                 e&#239;&#172;&#8364;ect observed decrease amplitude burst, <br /> Figure 9. Pre-steady-state kinetics MtATP-PRT inhibition L- <br />                                                                                 decrease burst steady-state rates. A <br /> histidine. (A) Representative traces MtATP-PRT reaction            decrease burst amplitude indicates L-histidine inhibits <br /> pre-steady-state conditions various L-histidine concentrations,          MtATP-PRT trapping form catalytic and <br /> &#239;&#172;?xed saturating concentrations ATP, PRPP, metals. Gray             inactive, severely slowing chemistry product <br /> lines represent data black lines best &#239;&#172;?ts eq 6. Data             release. On basis results sequential ordered <br /> averages 10 traces. (B) Plot burst amplitude vs L-histidine           kinetic mechanismc previously proposed ATP-PRTs, can <br /> concentration (top) plot kobs vs L-histidine concentration               inhibition using Scheme 3. Burton et al. elegantly <br /> (bottom). Symbols represent data solid lines best &#239;&#172;?ts eqs 10             demonstrated similar mechanism feedback allosteric <br /> and 11 burst amplitude burst rate dependencies, respectively. <br /> Reactions conducted 50 mM Tris-HCl (pH 8.5), 150 mM <br />                                                                                 inhibition E. coli D-3-phosphoglycerate dehydrogenase <br /> KCl, 10 mM MgCl2, 1.5 mM PRPP, 4 mM ATP, 10 &#206;&#188;M MtATP-                       (PGDH) L-serine.40 It important stress MtATP- <br /> PRT, 25 &#194;&#176;C. Results representative independent                    PRT PGDH structurally unrelated enzymes, which <br /> experiments.                                                                    catalyze di&#239;&#172;&#8364;erent types chemistry distinct <br />                                                                                 substrates. However, conservation allosteric <br />                                                                                 mechanism, e.g., sequestration enzyme&#226;&#710;&#8217;substrate&#226;&#710;&#8217; <br /> there dimer present gel &#239;&#172;?ltration (at pH 7.2),                   inhibitor complex nonproductive form, appears a <br /> CgATP-PRT loses activity pH 8.25                               successful case convergent evolution. <br />    If dimer&#226;&#710;&#8217;hexamer equilibrium does account                       On basis steady-state data, extent L-histidine <br /> allosteric inhibition, mechanism envisioned. It               inhibition maximal saturating ATP concentrations <br /> is noteworthy mention Cho colleagues16 observed                   (uncompetitive kinetic pattern) independent the <br /> large domain shift, domain III, dimeric form                          concentration PRPP [noncompetitive kinetic pattern (Kii = <br /> compared hexameric form. Although dimeric form                    Kis)]. Taken together, results steady-state pre-steady- <br /> is present experimental conditions, domain                    state experiments indicate k&#226;&#710;&#8217;6/k6 k&#226;&#710;&#8217;7/k7 ratios <br /> shift place, generating alternative hexamer,                (Scheme 3) similar, E&#226;&#710;&#8217;ATP&#226;&#710;&#8217; <br /> which inhibited. Regardless conforma-                  histidine E&#226;&#710;&#8217;ATP&#226;&#710;&#8217;PRPP&#226;&#710;&#8217;histidine complexes be <br /> tional change responsible L-histidine inhibition,                inactive forms MtATP-PRT. The structural basis this <br /> we propose MtATP-PRT functional hexamer                           e&#239;&#172;&#8364;ect de&#239;&#172;?ned lack structural <br />  <br /> Scheme 3 <br />  <br />  <br />  <br />  <br />                                                                          8035                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                            Article <br />  <br /> information regarding complexes MtATP-PRT                       0.4 40 &#206;&#188;M, correlate maximal variation <br /> substrates products, L-histidine.                          expected L-histidine M. tuberculosis. <br />     Ionic States L-Histidine Bound ATP-PRT. The                             Only ATP-PRT characterized regard <br /> de&#239;&#172;?nition ionic state L-histidine best binds             inhibition constants. Comparison value reported for <br /> best inhibits MtATP-PRT essential step                        Lactococcus lactis ATP-PRT indicates L-histidine levels <br /> molecular description inhibition, paves way              &#239;&#172;&#8218;uctuate 10-fold bacteria, Ki 81 &#206;&#188;M <br /> any rational approach target site. We &#239;&#172;?rst analyzed                    determined, pH 8.42 In S. enterica serovar Typhimurium, <br /> binding, using STD-NMR. The pH dependence STD-                          intracellular concentration L-histidine shown vary <br /> NMR clearly demonstrates L-histidine binds better                      15 100 &#206;&#188;M, depending growth <br /> MtATP-PRT higher pH values. More speci&#239;&#172;?cally, deproto-                      conditions.15 On basis values, concentration <br /> nation &#206;&#177;-amino group L-histidine increases extent                L-histidine M. tuberculosis range in <br /> of saturation transfer, correlates increased level               Salmonella Lactococcus. <br /> of binding. On basis identity residues involved                 Chemical Mechanism. A observations made <br /> in L-histidine binding, Asp218, Thr238, Ala273,                         regarding chemical mechanism MtATP-PRT. First, <br /> tentatively assign e&#239;&#172;&#8364;ect titration &#206;&#177;-amino group                MtATP-PRT displays unusual pH dependence, has <br /> of L-histidine (pKa &#226;&#710;&#188; 9). Although result likely              observed homologous enzymes.25 MtATP- <br /> physiological importance, cytoplasm reach pH 9,                PRT inactive pH &#226;&#8240;&#164;7, active neutral alkaline pH <br /> it hints potential mechanism preparing L-histidine                 values 9.5. The basis alkaline pH dependence is <br /> analogues bind tightly MtATP-PRT.                                      unknown, caused highly basic active site, <br />    Our kinetic results demonstrate L-histidine inhibition              bind phosphates substrates, by <br /> stronger (lower Ki values) near pH 8. This opposite result              missing protein partner, alter more <br /> obtained binding indicates form L-histidine               acidic pH. <br /> that best inhibits MtATP-PRT di&#239;&#172;&#8364;erent form L-                      Second, multiple-turnover experiments showed burst of <br /> histidine best binds it. Although IC50 measurements L-                 product formation, indicating step chemistry is <br /> histidine inhibition di&#239;&#172;&#8364;erent pH values performed                 partially rate-limiting MtATP-PRT. Unfortunately, are <br /> with ATP-PRTs, &#239;&#172;?rst report pH                         studies ATP-PRTs pre-steady-state <br /> dependence Ki L-histidine ATP-PRT. Bearing                       conditions, slow product release shown to <br /> mind IC50 values misleading                  ubiquitous trait phosphoribosyltransferases. <br /> into account concentration enzyme, substrates                   For example, quinolinate phosphoribosyltransferase been <br /> their saturation, inhibition type, etc., note inhibitory           shown display burst kinetics, indicating chemistry is <br /> behavior seen MtATP-PRT appears follow                        rate-limiting relatively slow (kobs = kcat = 0.4 s&#226;&#710;&#8217;1).43 In <br /> trend observed homologous enzymes S. enterica                    contrast, nicotinate phosphoribosyltransferase displayed burst <br /> and C. glutamicum.23,25 Speci&#239;&#172;?cally, higher pH values decrease                 kinetics, indicating fast chemistry (kobs &#226;&#8240;&#165; 500 s&#226;&#710;&#8217;1) slow <br /> the inhibitory e&#239;&#172;&#8364;ect L-histidine, appears                  product release (kcat = 1.2 s&#226;&#710;&#8217;1).44 <br /> correlates pKa &#206;&#177;-amino group. We emphasize                        Summary. Results presented indicate active L- <br /> that ionizable groups responsible transmission                histidine-inhibited MtATP-PRT hexameric solution. L- <br /> the inhibitory signal allosteric site active site          Histidine inhibition noncompetitive versus PRPP and <br /> certainly important, unfortunately,                     uncompetitive versus ATP. Inhibition MtATP-PRT L- <br /> observed narrow pH range                          histidine strongly in&#239;&#172;&#8218;uenced pH, reaching higher potency <br /> employed study catalysis inhibition.                                    closer physiological pH. Binding L-histidine displays the <br />    Finally, important explain &#226;&#8364;&#339;reverse                      opposite pH dependence observed inhibition, indicating <br /> protonation&#226;&#8364;? behavior likely unique L-histidine                 deprotonation &#206;&#177;-amino group increases level of <br /> and MtATP-PRT. Usually, allosteric regulation enzymes                    binding decreases level inhibition. Therefore, L- <br /> studied analysis binding inhibition, rarely             histidine binds inhibits MtATP-PRT neutral <br /> the pH dependence investigated. The                          imidazole ionized &#206;&#177;-amino &#206;&#177;-carboxyl groups. Pre- <br /> assumption dissociation constant (Kd) inhibition                  steady-state kinetic studies revealed step chemistry <br /> constant (Ki) allosteric inhibitors identical              partially rate-limiting L-histidine exerts inhibition <br /> oversimpli&#239;&#172;?cation. This likely case dealing                  decreasing catalytically active MtATP-PRT <br /> with inhibitors allosteric sites contain groups               (Scheme 3). <br /> with ionization constants near neutrality. As allosteric <br /> inhibitors discovered characterized, examples <br /> such likely found. <br />                                                                                &#226;&#8211;&#160;   AUTHOR INFORMATION <br />                                                                                Corresponding Author <br />     L-Histidine Biosynthesis M. tuberculosis. Two <br />                                                                                *MRC National Institute Medical Research, The Ridgeway, <br /> conclusions regarding L-histidine levels drawn                     Mill Hill, London NW7 1AA, U.K. Telephone: +44 (0)20 8816 <br /> our studies. Assuming ATP saturating concentration                  2358. Fax: +44 (0)20 8816 2730. E-mail: luiz.pedro@nimr.mrc. <br /> in cell,d half-maximal inhibition 4 &#206;&#188;M                  ac.uk. <br /> L -histidine, pH 8. This indicates physiological <br /> concentrations L-histidine varying                      Funding <br /> value able feedback control pathway. Speci&#239;&#172;?cally,                 Work L.P.S.d.C. laboratory funded MRC <br /> concentrations &#226;&#8240;&#164;0.4 &#206;&#188;M make MtATP-PRT                          (MC_UP_A253_1111). S.P. J.P.P. recipients of <br /> active, conversely, concentrations L-histidine &#226;&#8240;&#165;40 &#206;&#188;M                Erasmus Fellowships, European Commission. <br /> would inhibit MtATP-PRT shut L-histidine                    Notes <br /> biosynthesis M. tuberculosis. Therefore, range,                The authors declare competing &#239;&#172;?nancial interest. <br />                                                                         8036                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry <br />  <br /> &#226;&#8211;&#160; <br />                                                                                                                                                              Article <br />  <br />     ACKNOWLEDGMENTS                                                                 (4) Cook, P. F., Cleland, W. W. (2007) Enzyme Kinetics and <br />                                                                                   Mechanism, Garland Science Publishing, New York. <br /> We thank Dr. Steve Howell ESI-MS analysis MtATP-                             (5) Bearer, C. F., Neet, K. E. (1978) Threonine inhibition the <br /> PRT NIMR&#226;&#8364;&#8482;s Large Scale Laboratory E. coli growth. We                      aspartokinase-homoserine dehydrogenase I Escherichia coli. A slow <br /> thank Drs. Clarissa M. Czekster Rafael G. da Silva                        transient cooperativity inhibition aspartokinase activity. <br /> thoughtful discussions. All NMR spectra recorded                      Biochemistry 17, 3523&#226;&#710;&#8217;3530. <br /> MRC Biomedical NMR Centre, NIMR, Mill Hill (funded                               (6) Carvalho, L. P., Argyrou, A., Blanchard, J. S. (2005) Slow- <br /> MRC Grant-in-Aid U117533887).                                                     onset feedback inhibition: Inhibition Mycobacterium tuberculosis &#206;&#177;- <br />  <br />  <br /> &#226;&#8211;&#160; <br />                                                                                   isopropylmalate synthase L-leucine. J. Am. Chem. Soc. 127, 10004&#226;&#710;&#8217; <br />     ABBREVIATIONS                                                                 10005. <br />                                                                                     (7) Edfeldt, F. N., Folmer, R. H., Breeze, A. L. (2011) Fragment <br /> ATP-PRT, ATP phosphoribosyltransferase; PR-ATP, 1-(5-                             screening predict druggability (ligandability) lead discovery <br /> phospho-&#206;&#177;-D-ribosyl)-ATP; PPi, inorganic pyrophosphate;                           success. Drug Discovery Today 16, 284&#226;&#710;&#8217;287. <br /> PRPP, 5-phospho-&#206;&#177;-D-ribosyl pyrophosphate; SDS&#226;&#710;&#8217;PAGE,                                (8) Surade, S., Blundell, T. L. (2012) Structural biology drug <br /> sodium dodecyl sulfate&#226;&#710;&#8217;polyacrylamide gel electrophoresis;                        discovery difficult targets: The limits ligandability. Chem. Biol. 19, <br /> TEA, triethanolamine; BCA, bicinchoninic acid; BSA, bovine                        42&#226;&#710;&#8217;50. <br /> serum albumin; Tris, tris(hydroxymethyl)aminomethane; ESI-                          (9) Fenton, A. W. (2012) Identification allosteric-activating drug <br />                                                                                   leads human liver pyruvate kinase. Methods Mol. Biol. 796, 369&#226;&#710;&#8217; <br /> MS, electrospray ionization mass spectrometry; HEPES, 4-(2- <br />                                                                                   382. <br /> hydroxyethyl)piperazine-1-ethanesulfonic acid; NMR, nuclear                         (10) Luo, L., Parrish, C. A., Nevins, N., McNulty, D. E., Chaudhari, <br /> magnetic resonance; STD, saturation transfer di&#239;&#172;&#8364;erence;                           A. M., Carson, J. D., Sudakin, V., Shaw, A. N., Lehr, R., Zhao, H., <br /> PIPES, 1,4-piperazinediethanesulfonic acid; TAPS, N-[tris-                        Sweitzer, S., Lad, L., Wood, K. W., Sakowicz, R., Annan, R. S., Huang, <br /> (hydroxymethyl)methyl]-3-aminopropanesulfonic acid; CHES,                         P. S., Jackson, J. R., Dhanak, D., Copeland, R. A., Auger, K. R. <br /> 2-(cyclohexylamino)ethanesulfonic acid.                                           (2007) ATP-competitive inhibitors mitotic kinesin KSP that <br />  <br /> &#226;&#8211;&#160; <br />                                                                                   function allosteric mechanism. Nat. Chem. Biol. 3, 722&#226;&#710;&#8217;726. <br />      ADDITIONAL NOTES                                                               (11) Liu, S., Chang, J. S., Herberg, J. T., Horng, M. M., Tomich, P. K., <br /> a                                                                                 Lin, A. H., Marotti, K. R. (2006) Allosteric inhibition of <br />   Saturation transfer di&#239;&#172;&#8364;erence NMR (STD-NMR) 1H                             Staphylococcus aureus D-alanine:D-alanine ligase revealed crystallo- <br /> NMR method developed monitoring interaction                            graphic studies. Proc. Natl. Acad. Sci. U.S.A. 103, 15178&#226;&#710;&#8217;15183. <br /> small molecules proteins, resonance assign-                        (12) Ceccarelli, D. F., Tang, X., Pelletier, B., Orlicky, S., Xie, W., <br /> ments protein necessary.28,29 In method, &#239;&#172;?rst                 Plantevin, V., Neculai, D., Chou, Y. C., Ogunjimi, A., Al-Hakim, A., <br /> spectrum protein ligand obtained, followed                        Varelas, X., Koszela, J., Wasney, G. A., Vedadi, M., Dhe-Paganon, S., <br /> second spectrum radiofrequency ablated                            Cox, S., Xu, S., Lopez-Girona, A., Mercurio, F., Wrana, J., Durocher, <br /> resonances protein spin di&#239;&#172;&#8364;usion                           D., Meloche, S., Webb, D. R., Tyers, M., Sicheri, F. (2011) An <br /> bound ligand (saturation transfer). As ligand                           allosteric inhibitor human Cdc34 ubiquitin-conjugating enzyme. <br /> equilibrium bound free states, signals                    Cell 145, 1075&#226;&#710;&#8217;1087. <br />                                                                                     (13) Sousa, M. C., Kessler, B. M., Overkleeft, H. S., McKay, D. B. <br /> perturbed, ones bound ligand. Once                          (2002) Crystal structure HslUV complexed vinyl sulfone <br /> these spectra obtained, subtracted,                          inhibitor: corroboration proposed mechanism allosteric <br /> resulting di&#239;&#172;&#8364;erence spectrum reveals resonances                      activation HslV HslU. J. Mol. Biol. 318, 779&#226;&#710;&#8217;785. <br /> ligand a&#239;&#172;&#8364;ected, indicating direct contact protein.                       (14) Ames, B. N., Martin, R. G., Garry, B. J. (1961) The step <br /> b <br />   The amplitude burst observed pre-steady-state                      histidine biosynthesis. J. Biol. Chem. 236, 2019&#226;&#710;&#8217;2026. <br /> multiple-turnover conditions function factors: (i)                    (15) Winkler, M. E. (1987) Biosynthesis Histidine. In Escherichia <br /> the rate chemical step relative rate product                     coli Salmonella typhimurium: Cellular Molecular Biology <br /> release, (ii) internal equilibrium constant chemical                  (Neidhardt, F. C., Ed.) pp 395&#226;&#710;&#8217;411, American Society for <br /> step, active site, (iii) fraction active enzyme.37              Microbiology, Washington, DC. <br /> As goal studies complete                       (16) Cho, Y., Sharma, V., Sacchettini, J. C. (2003) Crystal <br /> kinetic mechanism MtATP-PRT, did attempt                             structure ATP phosphoribosyltransferase Mycobacterium <br />                                                                                   tuberculosis. J. Biol. Chem. 278, 8333&#226;&#710;&#8217;8339. <br /> determine amplitude burst lower                          (17) Cho, Y., Ioerger, T. R., Sacchettini, J. C. (2008) Discovery <br /> concentration MtATP-PRT.                                                       novel nitrobenzothiazole inhibitors Mycobacterium tuberculosis <br /> c <br />  Scheme 3 shows sequential ordered kinetic mechanism,                         ATP phosphoribosyl transferase (HisG) virtual screening. J. <br /> with binding ATP followed binding PRPP. Product                          Med. Chem. 51, 5984&#226;&#710;&#8217;5992. <br /> release shown ordered, PPi dissociating &#239;&#172;?rst                        (18) Griffin, J. E., Gawronski, J. D., Dejesus, M. A., Ioerger, T. R., <br /> followed PR-ATP. This kinetic mechanism observed                           Akerley, B. J., Sassetti, C. M. (2011) High-resolution phenotypic <br /> with SeATP-PRT.19                                                                 profiling defines genes essential mycobacterial growth and <br /> d                                                                                 cholesterol catabolism. PLoS Pathog. 7, e1002251. <br />   The concentration ATP M. tuberculosis unknown, but <br /> cells typically contain 1 10 mM ATP. This range                         (19) Parish, T. (2003) Starvation <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-82' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span>survival</span> response Mycobacterium <br /> corresponds roughly 5&#226;&#710;&#8217;50 times Km ATP.                                 tuberculosis. J. Bacteriol. 185, 6702&#226;&#710;&#8217;6706. <br />  <br />  <br /> &#226;&#8211;&#160; <br />                                                                                     (20) Voll, M. J., Appella, E., Martin, R. G. (1967) Purification <br />                                                                                   composition studies phosphoribosyladenosine triphosphate:- <br />     REFERENCES                                                                    pyrophosphate phosphoribosyltransferase, enzyme histidine <br />  (1) Pardee, A. B., Yates, R. A. (1956) Control pyrimidine                 biosynthesis. J. Biol. Chem. 242, 1760&#226;&#710;&#8217;1767. <br /> biosynthesis Escherichia coli feedback mechanism. J. Biol. Chem.            (21) Brashear, W. T., Parsons, S. M. (1975) Evidence a <br /> 221, 757&#226;&#710;&#8217;770.                                                                     covalent intermediate a <br /> </body></html>